预防性经皮内镜胃造瘘术在接受放化疗的头颈部肿瘤患者中的应用

doi:10.19438/j.cjoms.2018.02.014

中国口腔颌面外科杂志 ›› 2018, Vol. 16 ›› Issue (2): 167-170.doi: 10.19438/j.cjoms.2018.02.014

预防性经皮内镜胃造瘘术在接受放化疗的头颈部肿瘤患者中的应用

钱立¹, 葛奎¹, 徐兵¹, 吴嘉骏¹, 王繁麟¹, 范晶娴¹, 张霖²

1.上海交通大学医学院附属第九人民医院急诊科,2.放疗科,上海 200011;

收稿日期:2017-09-18 修回日期:2017-12-03 出版日期:2018-03-20 发布日期:2018-04-08
通讯作者: 葛奎,E-mail：kge723@163.com
作者简介:钱立（1978-）,男,硕士,主治医师,E-mail：ericqian2010@icloud.com
基金资助:
上海交通大学医学院医工交叉项目（YG2016MS12）

Prophylactic percutaneous endoscopic gastrostomy in patients with head and neck cancer undergoing radiotherapy and chemotherapy

QIAN Li¹, GE Kui¹, XU Bing¹, WU Jia-jun¹, WANG Fan-lin¹, FAN Jing-xian¹, ZHANG Lin²

1.Department of Emergency, 2.Department of Radiation Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine. Shanghai 200011, China;

Received:2017-09-18 Revised:2017-12-03 Online:2018-03-20 Published:2018-04-08

摘要/Abstract

摘要： 目的: 探讨拟接受放化疗头颈肿瘤患者胃造瘘的时机。 方法: 回顾分析2016年1月—12月间接受放化疗的头颈肿瘤患者,由放疗科医师根据营养风险评估,估计存在营养障碍问题,拟行经皮内镜胃造瘘术（PEG）,分为放化疗前预防性胃造瘘组（预防性PEG组）和放化疗期间胃造瘘组（反应性PEG组）,其中预防性PEG组234例,反应性PEG组93例。检测2组患者置管前、后的体重、白蛋白水平,计算并比较置管前、后BMI及白蛋白变化程度;观察2组患者耐管及创面感染情况,比较2组放疗结束后拔管率的变化。采用SPSS 11.5软件包对2组患者的数据进行团体t检验和χ²检验。 结果: 放化疗结束后,预防性PEG组BMI、白蛋白值及拔管率均显著高于反应性PEG组（P<0.01）,而预防性PEG组的感染率显著低于被动性PEG组（P<0.05）。 结论: 预防性PEG术能改善头颈部肿瘤患者接受放化疗后的营养状况,减轻放化疗引起的并发症。

关键词: 经皮内镜下胃造瘘术, 头颈部肿瘤, 预防性PEG, 被动性PEG

Abstract: PURPOSE: To investigate the timing of percutaneous endoscopic gastrostomy (PEG) in patients with head and neck cancer undergoing radiotherapy and chemotherapy. METHODS: This retrospective study analyzed the data of patents with head and neck cancer who underwent radio-chemotherapy from January 2016 to December 2016 (patients required gastrostomy according to nutritional risk assessed by radiotherapy physicians). With informed consent the patients were divided into chemotherapy before gastrostomy (prophylactic PEG group) and chemotherapy during gastrostomy (reactive PEG group). There were 234 cases in prophylactic PEG group and 93 cases in reaction PEG group. BMI and albumin level of patients were recorded and analyzed before and after cathetering. Wound infections and extubation rates of the two groups were also recorded and compared. SPSS 11.5 software package was used for comparison between the two groups. RESULTS: After chemotherapy and radiotherapy, BMI, albumin and extubation rates of the prophylactic PEG group were significantly higher than those of the reactive PEG group (P<0.01), while the infection rate in the prophylactic PEG group was significantly lower than that in the reactive PEG group (P<0.05). CONCLUSIONS: Prophylactic PEG can improve the nutritional status of patients with head and neck cancer after radiotherapy and chemotherapy, and reduce complications of radiotherapy and chemotherapy.

Key words: Percutaneous endoscopic gastrostomy, Head and neck cancer, Prophylactic PEG, Reactive PEG

中图分类号:

R739.8

钱立, 葛奎, 徐兵, 吴嘉骏, 王繁麟, 范晶娴, 张霖. 预防性经皮内镜胃造瘘术在接受放化疗的头颈部肿瘤患者中的应用[J]. 中国口腔颌面外科杂志, 2018, 16(2): 167-170.

QIAN Li, GE Kui, XU Bing, WU Jia-jun, WANG Fan-lin, FAN Jing-xian, ZHANG Lin. Prophylactic percutaneous endoscopic gastrostomy in patients with head and neck cancer undergoing radiotherapy and chemotherapy[J]. China J Oral Maxillofac Surg, 2018, 16(2): 167-170.

参考文献

[1] Cady J.Nutritional support during radiotherapy for head and neck cancer: the role of prophylactic feeding tube placement[J]. Clin J Oncol Nurs, 2007, 11(6): 875-880.
[2] Brizel DM, Albers ME, Fisher SR, et al.Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer[J]. New Engl J Med, 1998, 338(25): 1798-1804.
[3] Lee H, Havrila C, Bravo V, et al.Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma[J]. Support Care Cancer, 2008, 16(3): 285-289.
[4] Machtay M, Rosenthal DI, Hershock D, et al.Organ preservation therapy using induction plus concurrent chemoradiation for advanced respectable oropharyngeal carcinoma: a University of Pennsylvania phase II trial[J]. J Clin Oncol, 2002, 20(19): 3964-3971.
[5] Kubrak C, Olson K, Jha N, et al.Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment[J]. Head Neck, 2010, 32(3): 290-300.
[6] Sobotka L 著, 蔡威译. 临床营养基础 [M]. 第3版. 上海: 复旦大学出版社, 2007: 418.
[7] 张志愿, 郑家伟, 王中和. 晚期头颈鳞癌: 术前放疗还是术后放疗?[J]. 中国口腔颌面外科杂志, 2009, 7(1): 2-3.
[8] James SS, Phillip RS, Michelle MR, et al.Prophylactic placement of gastrostomy feeding tubes before radiotherapy in patients with head and neck cancer: is it worthwhile[J]. J Clin Gastroenterol, 2001, 33(3): 215-217.
[9] Madhoun MF, Blankenship MM, Blankenship DM, et al.Prophylactic PEG placement in head and neck cancer: how many feeding tubes are unused (and unnecessary)?[J]. World J Gastroenterol, 2011, 17(8): 1004-1008.
[10] Chasen MR, Bhargava R.A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer[J]. Support Care Cancer, 2009, 17(11): 1345-1351.
[11] Sanguineti G, Sormani MP, Marur S, et al.Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer[J]. Int J Radiat Oncol Biol Phys, 2012, 83(1): 235-242.
[12] Le QT, Kim HE, Schneider CJ, et al.Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study[J]. J Clin Oncol, 2001, 29(20): 2808-2814.
[13] Bossi P, Locati LD, Lictra L.Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profile[J]. J Clin Oncol, 2012, 30(5): 564-565.
[14] Gussgard AM, Hope AJ, Jokstad A, et al.Assessment of cancer therapy-induced oral mucositis using a patient reported oral mucositis experience questionnaire[J]. PLos One, 2014, 9(3): e91733.
[15] Habib SF, Ahmed S, Skelly R, et al.Developing a protocol for gastrostomy tube insertion in patients diagnosed with head and neck cancer[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 117(5): 551-559.
[16] 葛奎, 徐兵, 张霖, 等. 经皮内镜胃造瘘营养支持在头颈部肿瘤放疗中的应用[J]. 中国口腔颌面外科杂志, 2013, 11(4): 308-311.
[17] Anonymous. American Gastroenterological Association medical position statement: guidelines for the use of enteral nutrition[J]. Gastroenterology, 1995, 108(4): 1280-1281.
[18] Wygoda A, Rutkowski T, Hutnik M, et al.Acute mucosal reactions in patients with head and neck cancer. Three patterns of mucositis observed during radiotherapy[J]. Strahlenther Onkol, 2013, 189(7): 547-551.

预防性经皮内镜胃造瘘术在接受放化疗的头颈部肿瘤患者中的应用

Prophylactic percutaneous endoscopic gastrostomy in patients with head and neck cancer undergoing radiotherapy and chemotherapy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 9

编辑推荐

Metrics

本文评价

[1]	陈伟良. 延长垂直下斜方肌岛状肌皮瓣修复重建大型头颈部缺损[J]. 中国口腔颌面外科杂志, 2023, 21(1): 1-10.
[2]	曾丽婷, 吴嘉骏, 范晶娴, 王伟, 杨天页, 王繁麟, 徐兵, 葛奎. 拉出法与插入法经皮内镜下胃造瘘术在口腔颌面部恶性肿瘤患者中的应用效果比较[J]. 中国口腔颌面外科杂志, 2022, 20(4): 401-404.
[3]	樊文慧, 石慧烽, 涂文勇. 2种不同形变配准软件在头颈部勾画中的作用评价[J]. 中国口腔颌面外科杂志, 2021, 19(6): 517-524.
[4]	劳峥, 毕帆, 樊文慧, 胡海生, 涂文勇, 石慧烽. 去伪影算法对头颈部肿瘤患者钛板植入术后放疗的剂量影响[J]. 中国口腔颌面外科杂志, 2021, 19(3): 248-252.
[5]	毛蓓茜, 黄瑶, 吴薇, 罗吴亮, 徐兵, 寿宇雁. 健康教育路径在口腔颌面头颈部肿瘤经皮内镜胃造瘘患者中的临床应用评价[J]. 中国口腔颌面外科杂志, 2020, 18(5): 442-446.
[6]	王绍杰, 张瑞, 杨涛, 王维戚, 魏建华. 头颈部肿瘤皮瓣修复术后上消化道出血死亡病例2例分析[J]. 中国口腔颌面外科杂志, 2020, 18(1): 91-93.
[7]	黄瑶, 俞蕾蕾, 杨悦来, 王惠芬, 袁卫军, 茅越丽. 头颈部肿瘤患者症状群评估工具的研究进展[J]. 中国口腔颌面外科杂志, 2019, 17(5): 473-477.
[8]	王绍杰，隋明爽，许丹，刘春丽，谭学新，孙长伏. 导航技术在头颈部肿瘤应用专题的文献计量学研究[J]. 中国口腔颌面外科杂志, 2017, 15(3): 268-272.
[9]	葛奎;徐兵;张霖;曹大春;朱健;周龙女. 经皮内镜胃造瘘营养支持在头颈部肿瘤放疗中的应用 [J]. 中国口腔颌面外科杂志, 2013, 11(4): 308-311.